NCT06499090View on ClinicalTrials.gov

Mirtazapine for Acute and Chronic Post Mastectomy Pain

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Breast Cancer
Interventions
DRUG

Mirtazapine 30 MG

patients will receive orally the night before surgery the study medication and daily up to two weeks after Mirtazapine 30 mg tablet

DRUG

Placebo

patients will receive orally the night before surgery the study medication and daily up to two weeks after placebo tablet

Trial Locations (1)

Unknown

south Egypt Cancer Institute Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER